SCHEMBL13078675

SCHEMBL13078675

CCCN(CCC)Cc1ccc(C(=O)Nc2ccc(CNCI)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ RORC P51449 9/20 0.48
▸ HDAC8 Q9BY41 2/20 0.44
▸ HDAC6 Q9UBN7 2/20 0.44
▸ TRPV1 Q8NER1 1/20 0.43
▸ CA12 O43570 2/20 0.43
▸ CA1 P00915 2/20 0.43
▸ CA9 Q16790 2/20 0.43
▸ BDKRB2 P30411 1/20 0.43
▸ POLB P06746 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ HDAC3 O15379 1/20 0.42
▸ HDAC4 P56524 1/20 0.42
▸ HDAC1 Q13547 1/20 0.42
▸ HDAC7 Q8WUI4 1/20 0.42
▸ HDAC2 Q92769 1/20 0.42
▸ HDAC9 Q9UKV0 1/20 0.42
▸ HDAC5 Q9UQL6 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1206261 0.82 HDAC6 (0.59) RORCHDAC8HDAC6TRPV1CA12
SCHEMBL27611454 0.82 RORC (0.65) RORCHDAC6TRPV1CA12CA1
SCHEMBL12894415 0.80 CXCR4 (0.55) RORCCA12CA9BDKRB2
SCHEMBL1207206 0.80 RORC (0.44) RORC
SCHEMBL1206752 0.79 MEN1 (0.45) RORCTRPV1CA12CA9BDKRB2
SCHEMBL1205947 0.78 NAMPT (0.58) RORCHDAC6HDAC1
SCHEMBL1206643 0.74 CXCR4 (0.51) RORCHDAC8HDAC6TRPV1CA12
SCHEMBL12894119 0.74 MCHR1 (0.46) RORCHDAC8HDAC6TRPV1CA12
SCHEMBL1205268 0.74 CXCR4 (0.51) RORCHDAC8HDAC6TRPV1CA12
SCHEMBL1206565 0.74 RORC (0.47) RORCHDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7833991-B2 For use as antimetastatic agent or antiviral agent for HIV infection; N-(4-dipropylaminomethylphenyl)-4-{[(1H-imidazol-2-ylmethyl)-(1-methyl-1H-imidazol-2-ylmethyl)-amino]-methyl}-benzamide; chemokine receptor CXCR4 antagonists KUREHA CORPORATION (JP) 2010-11-16 — — US disclosed
Send feedback